Symptomdx.

Get Started

Pediatric Fever By Age 29 to 60 DaysAPPROACH

PEDIATRICS · 19 SECTIONS

⚲

462 items

☷ Legend

⚲

Resuscitation and Universal Approaches9▾

Chest and Cardiovascular12▾

Respiratory11▾

Abdominal and Gastrointestinal24▾

Renal and Urinary7▾

Neurologic11▾

Back and Neck8▾

Women's Health, Pregnancy, and GU11▾

Infectious Disease and Fever Syndromes11▾

Allergy and Dermatology7▾

Musculoskeletal and Extremities14▾

Trauma and Wounds14▾

ENT, Eye, Dental10▾

Endocrine, Metabolic, and Abnormal Labs9▾

Toxicology and Behavioral14▾

Pediatrics16▾

Fever In The Neonate And Young Infant Pediatric Fever By Age 0 To 28 Days Pediatric Fever By Age 29 To 60 Days Pediatric Fever By Age 2 To 24 Months Pediatric Respiratory Distress Croup And Stridor In Children Pediatric Dehydration Pediatric Abdominal Pain Febrile Seizure Rash In The Child Poor Feeding And Lethargy In The Infant Vomiting In The Child Diarrhea In The Child Pediatric Trauma Evaluation Brief Resolved Unexplained Event In The Infant And Apparent Life Threatening Event Concern Lethargy And Altered Mental Status In The Child

Environmental and Exposure4▾

01History/hx50

Inclusion and exclusions

›Febrile infant definition and scope

›Age 29 to 60 days

›Documented rectal temperature at or above 38.0 C at home or in ED

›Well appearing at presentation

›Term or corrected gestational age at or above 37 weeks

›No major comorbidities altering pathway

›Exclusions from standard low risk pathways

›Toxic appearance or shock

›Prematurity below 37 weeks or corrected age below 37 weeks

›Significant congenital heart disease

›Chronic lung disease with oxygen need

›Known immunodeficiency or immunosuppressive therapy

›Indwelling central line or shunt

›Recent hospitalization or invasive procedure

Fever and symptom timeline

›Time course and context

›Time of first fever

›Duration of fever

›Maximum recorded temperature

›Antipyretic use and response

›Pattern of fever recurrence

›Associated symptoms

›Poor feeding

›Decreased wet diapers

›Vomiting

›Diarrhea

›Cough

02Alarm Features/alarm27

Immediate escalation triggers

›Resuscitation triggers

›Apnea

›Cyanosis

›Persistent hypoxia

›Shock signs

›Delayed capillary refill

›Mottling

›Weak pulses

›Altered mental status

›Seizure

›Bulging fontanelle with altered mental status

›High risk exam features

›Ill appearance

›Poor perfusion

›Neck stiffness

›Petechiae or purpura

›Focal neurologic deficit

›Respiratory distress

Vital sign danger patterns

›Age specific danger patterns

›Hypothermia

›Persistent tachycardia not explained by fever

›Bradypnea or apnea

›Persistent tachypnea

›Hypotension

›Fever pattern suggesting higher risk

›Very high fever or rapidly rising fever

03Medications/meds15

Current and recent medications

›Home medications and dosing history

›Acetaminophen exposure

›Ibuprofen exposure

›Any prior antibiotics in last 72 hours

›Recent vaccines in last 48 hours

›Medication risk modifiers

›Recent systemic corticosteroids

›Immunosuppressants

›Prophylactic antibiotics

Contraindications and interaction traps

›Febrile infant medication cautions

›Avoid ibuprofen if dehydration concern

›Avoid empiric oral antibiotics before cultures when possible

›Allergy history

›Beta lactam allergy features

›Prior anaphylaxis history

04Diet/diet14

Feeding and hydration status

›Intake pattern

›Breastfeeding adequacy

›Formula intake volume change

›Emesis with feeds

›Hydration indicators

›Wet diapers count in last 24 hours

›Tears

›Dry mucous membranes

Exposure related risks

›Recent feeding changes

›New formula or fortifier

›Introduction of solids

›Household exposures

›Unpasteurized products exposure

›Sick caregiver preparing feeds

05Review of Systems/ros27

General and constitutional

›System screen

›Activity change

›Sleepiness

›Consolability

›Cry strength

›Weight gain trajectory

System based symptoms

›Respiratory

›Cough

›Congestion

›Wheeze

›Increased work of breathing

›Gastrointestinal

›Vomiting

›Diarrhea

›Blood in stool

›Genitourinary

›Foul urine

›Decreased urination

›Skin and soft tissue

›Rash

›Vesicles

›Cellulitis signs

›Neurologic

›Seizure like activity

›Abnormal tone

›Bulging fontanelle

06Collateral History and Family History/chafh16

Collateral and exposure history

›Source reliability and exposure context

›Primary caregiver historian

›Daycare exposure

›Household sick contacts

›Recent travel

›Animal exposures

›Infection exposures

›Known influenza exposure

›RSV exposure

›COVID exposure

›Pertussis exposure

Family history relevant to severe infection

›Inherited and household risks

›Primary immunodeficiency history

›Sickle cell disease history

›Early infant deaths unexplained

›Recurrent severe bacterial infections in family

07Risk Factors/rf18

Host risk factors for invasive bacterial infection

›Baseline vulnerabilities

›Prematurity history

›Prior NICU stay

›Prior invasive bacterial infection

›Congenital anomalies

›Healthcare exposure risks

›Recent hospitalization

›Recent antibiotics

›Recent urinary catheterization

Source specific risk factors

›UTI risk factors

›Uncircumcised male

›Prior UTI

›Known urinary tract abnormality

›HSV risk factors

›Vesicular rash

›Seizure

›Elevated liver enzymes

›Maternal HSV lesions around delivery

08Differential Diagnosis/ddx32

Life threatening and cannot miss

›Invasive bacterial infection

›Bacteremia (R78.81)

›Bacterial meningitis (G00.9)

›Sepsis (A41.9)

›Septic shock (R57.2)

›Focal bacterial infections

›Pyelonephritis or febrile UTI (N39.0)

›Pneumonia (J18.9)

›Osteomyelitis (M86.9)

›Septic arthritis (M00.9)

›Cellulitis (L03.90)

›Viral infections with high acuity potential

›HSV infection (B00.9)

›Influenza (J10.1)

›RSV bronchiolitis (J21.0)

Common diagnoses

›Viral syndromes

›Viral upper respiratory infection (J06.9)

›Viral gastroenteritis (A08.4)

›COVID 19 (U07.1)

›Urinary tract infection

›Cystitis (N30.90)

›Pyelonephritis (N10)

Less common and mimics

›Noninfectious

›Vaccine related fever

›Heat related illness

09Past Medical History/pmh13

Baseline health and prior evaluations

›Neonatal and infant history

›Prior ED visits for fever

›Prior cultures and results

›Prior lumbar puncture

›Known conditions and devices

›Congenital anomalies

›Cardiac disease

›VP shunt

›Central line

Immunizations and growth

›Preventive care status

›Immunizations up to date for age

›Recent immunizations in last 48 hours

›Growth trajectory concerns

10Physical Exam/exam39

General appearance and perfusion

›Toxicity and stability

›Alertness and interaction

›Consolability

›Cry strength

›Hydration status

›Capillary refill

›Skin mottling

›Vital signs interpretation

›Persistent tachycardia after antipyresis

›Work of breathing and oxygenation

›Temperature measurement method

System exam

›Head and neck

›Fontanelle

›Neck stiffness

›Otitis signs

›Lungs

›Retractions

›Grunting

›Focal crackles

›Cardiovascular

›Pulses

›Murmur

›Hepatomegaly

›Abdomen

›Distension

›Tenderness

11Lab Studies/labs29

Core testing for 29 to 60 days

›Standard evaluation set

›Urinalysis with microscopy

›Urine culture

›Blood culture

›CBC with differential

›Inflammatory markers

›Procalcitonin preferred

›CRP if procalcitonin unavailable

›ANC interpretation with CBC

›Interpreting key results

›Positive urinalysis suggests UTI source

›Elevated inflammatory markers increase invasive bacterial infection risk

When to add CSF studies

›Lumbar puncture decision logic

›Any ill appearance or neurologic concern

›Any high risk inflammatory marker profile

›Persistent clinician concern despite low risk markers

›Antibiotics planned and meningitis not ruled out

›CSF panel components

›Cell count and differential

›Glucose with paired serum glucose

›Protein

›Gram stain and culture

›Viral PCR local protocol dependent

Additional labs based on presentation

›Targeted add ons

›Serum electrolytes and glucose if dehydration or lethargy

12Imaging/img38

Scoring Systems

›Clinical decision tools for IBI risk

›PECARN febrile infant rule

›Low risk criteria

›Urinalysis negative

›ANC at or below 4090 per microliter

›Procalcitonin at or below 1.71 ng per mL

›Not for ill appearing infants

›Hemodynamic instability

›Focal CNS signs

›Step by Step approach

›Low risk criteria

›Well appearing

›Age over 21 days

›Urinalysis negative

›Procalcitonin below 0.5 ng per mL

›CRP at or below 20 mg per L

›ANC at or below 10000 per microliter

›Pitfalls

›Early infection may have normal CRP

›Antibiotics before sampling invalidates culture interpretation

MRI

›Indications in febrile infant

›Suspected spinal epidural infection

›Suspected osteomyelitis when radiographs nondiagnostic

›Constraints and safety

›Need for sedation in young infants

›Limited ED availability local protocol dependent

13Special Tests/spec13

Urine acquisition and interpretation

›Collection method

›Catheterized specimen preferred for culture

›Bag specimen acceptable only for screening urinalysis

›Urinalysis interpretation pearls

›Leukocyte esterase or nitrite supports UTI

›Pyuria on microscopy supports UTI

›Negative urinalysis lowers likelihood of UTI

Viral testing and focused diagnostics

›Respiratory viral testing local protocol dependent

›Influenza and RSV during season

›SARS CoV 2 testing based on local policy

›Focused infection testing

›HSV PCR if vesicles or seizure

›Chest radiograph if focal lung findings

14ECG/ecg8

When ECG is relevant

›Indications

›Unexplained persistent tachycardia after antipyresis

›Suspected myocarditis

›Poor perfusion with disproportionate tachycardia

High risk patterns prompting escalation

›Concerning findings

›Supraventricular tachycardia

›Heart block

›ST segment changes with myocarditis concern

15Assessment/ax19

Problem representation and risk category

›Working assessment framing

›Well appearing febrile infant 29 to 60 days

›Source identified versus no source

›Low risk versus high risk for invasive bacterial infection

›Low risk profile elements

›Urinalysis negative

›Inflammatory markers not elevated

›No focal bacterial source on exam

›Higher risk profile elements

›Urinalysis positive

›Elevated inflammatory markers

›Concern for meningitis

›Inability to ensure reliable follow up

Diagnostic uncertainty and alternatives

›Uncertain source considerations

›Early bacterial infection with normal markers

›Viral illness with coincident UTI

›Must not miss alternatives

›HSV disease features

›Osteoarticular infection signs

16Plan/plan42

Differential Management

›!pediatric fever 29 to 60 days→›!Bacterial meningitis→›Urinary tract infection (uncomplicated)→

First 5 minutes workflow

›Stabilization and monitoring

›Continuous pulse oximetry if any respiratory concern

›Cardiac monitor if poor perfusion or persistent tachycardia

›IV or IO access if ill appearing or dehydration

›Point of care glucose if lethargy or seizure

›Early targets

›Cultures before antibiotics when feasible

›Antipyresis and reassessment of appearance

Diagnostic pathway for well appearing 29 to 60 days

›Baseline testing sequence

›Urinalysis and urine culture

›Blood culture

›CBC and inflammatory markers

›LP decision based on risk

›If inflammatory markers elevated then lumbar puncture

›If inflammatory markers normal and urinalysis negative then lumbar puncture optional

›If urinalysis positive and inflammatory markers normal then lumbar puncture usually not required local protocol dependent

Empiric antimicrobials and dosing

›If meningitis suspected or CSF abnormal

›Ceftriaxone 50 mg per kg IV or IM every 24 hours

›Vancomycin 15 mg per kg IV every 6 hours local protocol dependent

›If bacteremia risk without meningitis and cultures obtained

›Ceftriaxone 50 mg per kg IV or IM every 24 hours

17Disposition/dispo24

ICU and high acuity indications

›ICU level care criteria

›Shock or need for vasoactive support

›Apnea or need for ventilatory support

›Seizure with persistent altered mental status

›Suspected meningitis with instability

Admission and observation indications

›Inpatient admission criteria

›CSF obtained and abnormal or pending with antibiotics started

›High risk inflammatory markers

›Inability to ensure reliable 24 hour follow up

›Social concerns or transportation barriers

›Observation pathway candidates

›Well appearing with pending cultures

›Borderline risk markers with shared decision making

Discharge eligibility criteria

›Home observation candidates

›Well appearing

›Urinalysis negative

›Inflammatory markers not elevated

›No CSF needed or CSF reassuring if obtained

›Reliable caregiver and access to care

›Clear plan for follow up within 24 hours

›If UTI treated as outpatient

›Tolerating feeds

›First dose given and prescription filled plan

›Follow up within 24 hours

18Discharge Instructions/di23

Copy discharge instructions

›Your baby has a fever and was checked for serious infections

›Blood and urine tests were done

›A blood culture and urine culture were sent and results take 1 to 2 days

›Medications

›Use acetaminophen only as directed for age and weight

›Do not use ibuprofen unless you were told it is safe

›If antibiotics were prescribed take every dose as directed

›Feeding and hydration

›Encourage regular feeds

›Watch wet diapers and hydration

›Follow up

›Follow up appointment within 24 hours

›Return for a recheck sooner if symptoms worsen

›Return to the ED now for any of these

›Trouble breathing

›Blue color or pauses in breathing

›Very sleepy or hard to wake

›Weak cry or not feeding

›Fewer wet diapers than usual

›New rash with spots that do not blanch

›Seizure

›Vomiting that prevents keeping feeds down

›Fever that persists or any new concern

19References/r15

Guidelines and decision tools

›American Academy of Pediatrics Clinical Practice Guideline Evaluation and Management of Well Appearing Febrile Infants 8 to 60 Days Old 2021

›Risk stratified approach using urinalysis blood culture and inflammatory markers

›LP and antibiotics selective in 29 to 60 days based on risk

›Canadian Paediatric Society Position Statement Management of Well Appearing Febrile Young Infants Aged 90 Days or Younger 2024

›Provides 29 to 60 day pathway and estimated invasive bacterial infection rates

›Endorses risk stratification with inflammatory markers and urinalysis

›Kuppermann et al PECARN clinical prediction rule for febrile infants 60 days and younger JAMA Pediatrics 2019

›Uses urinalysis ANC and procalcitonin to identify low risk infants

›Supports reduced LP and antibiotics in low risk profiles

›Gomez et al Step by Step approach for febrile infants 90 days or younger 2016

›Uses appearance age urinalysis procalcitonin CRP and ANC

›Focuses on identifying low risk invasive bacterial infection

›American Academy of Pediatrics Urinary Tract Infection guideline for 2 to 24 months 2011

›Urine collection and interpretation principles applicable to infant evaluation

›Imaging considerations after febrile UTI local protocol dependent

Evidence & Review

Reviewed by SymptomDx Medical Team · Last reviewed February 24, 2026

SymptomDx is an educational tool for medical professionals. It does not replace clinical judgment. Verify all clinical data and drug dosages with authoritative sources.